The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 328.00
Bid: 325.50
Ask: 330.00
Change: 0.00 (0.00%)
Spread: 4.50 (1.382%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 328.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 recovers 1% on energy, healthcare stock boost; Entain jumps

Tue, 21st Sep 2021 09:14

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Kingfisher top FTSE 100 loser despite positive results

* Royal Dutch Shell sells U.S. oilfield assets

* Stagecoast surges on merger talks with rival

* FTSE 100 up 1.0%, FTSE 250 adds 0.8%
(Updates to close)

By Shashank Nayar

Sept 21 (Reuters) - London's FTSE 100 rebounded on Tuesday,
aided by gains in energy and healthcare stocks, and Entain
jumped to the top of the index after the Ladbrokes owner said it
received an offer from DraftKings.

The blue-chip FTSE 100 ended 1.0% higher and
recorded its best session in two months. Oil major BP and
Royal Dutch Shell were among the top boosts.

Entain jumped 18.0%, leading gains on travel and
leisure stocks, after it confirmed that U.S.
fantasy sports betting company DraftKings has made an
offer to buy the British gambling firm in a deal that one media
report said could be valued at $20 billion.

The FTSE 100 has gained 8% so far this year on support from
dovish central bank policies and re-opening optimism. However,
higher inflation pressures have raised scepticism among
investors that central banks might hint later this week towards
pulling back massive asset purchases sooner than expected.

"Investors are still progressing ahead with fingers crossed
as the Fed and the BoE are unlikely to declare any tapering
measures this time, as it would potentially unsettle the global
equity environment before the third-quarter earnings season,"
said Kunal Sawhney, chief executive at Kalkine.

Healthcare stocks gained 1.5% with drugmakers
including AstraZeneca, Indivior, Oxford
BioMedica up between 1.6% and 4.8%.

The domestically focussed mid-cap index rose 0.8%,
with travel stocks being among the top gainers.

In earnings-driven moves, Kingfisher fell 4.9% to
the bottom of the FTSE 100 even as the British home improvement
retailer reported a jump in first-half profit.

Royal Dutch Shell jumped 3.6% after it said it would sell
its Permian Basin assets to ConocoPhillips for $9.5
billion in cash, exiting the largest U.S. oilfield.

British transport company Stagecoach Group surged
27.0% to the top of mid-cap index, after it said it was in talks
with rival operator National Express about a possible
all-share merger. National Express was up 7.6%.

Semiconductor technology company Alphawave jumped
19.4% on raising its 2021 guidance after reporting a 140% rise
in first-half revenue.
(Reporting by Shashank Nayar and Amal S in Bengaluru; Editing
by Saumyadeb Chakrabarty, Subhranshu Sahu and Marguerita Choy)

More News
25 May 2021 09:35

BROKER RATINGS: Royal Mail boosted to Buy from Hold by Peel Hunt

BROKER RATINGS: Royal Mail boosted to Buy from Hold by Peel Hunt

Read more
25 May 2021 08:22

LONDON BRIEFING: Shaftesbury seeing new demand for space in West End

LONDON BRIEFING: Shaftesbury seeing new demand for space in West End

Read more
21 May 2021 17:17

DIRECTOR DEALINGS: PageGroup CEO and Schroder chair sell shares

DIRECTOR DEALINGS: PageGroup CEO and Schroder chair sell shares

Read more
20 May 2021 16:07

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
18 May 2021 17:00

LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data

LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data

Read more
18 May 2021 12:12

LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42

LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42

Read more
18 May 2021 11:52

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Read more
18 May 2021 09:23

UPDATE 2-FTSE 100 flat as Vodafone loss offsets gains in banks; Oxford Biomedica shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Oxford Biomedica rises on robust outlook* Vodafone drops after missing earnings expectations* FTSE 100 up 0.2%, FTSE 250 adds 0.6% (Update...

Read more
18 May 2021 08:45

LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark

LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark

Read more
18 May 2021 08:13

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.

Read more
18 May 2021 07:47

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

Read more
28 Apr 2021 09:23

UPDATE 2-EU demands immediate access to UK-made vaccines in AstraZeneca legal battle

* EU demands faster deliveries in first hearing of legal case* AstraZeneca says lower supplies not in breach of contract* EU, UK vie for doses, Astra has under-delivered to both* Next hearings on May 26, EU seeks verdict before end of June (recast...

Read more
16 Apr 2021 09:49

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

Read more
15 Apr 2021 09:02

Oxford Biomedica swings to EBITDA profit

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.

Read more
15 Apr 2021 09:00

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.